| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 10/10/2006 | US7119166 Universal procedure for refolding recombinant proteins |
| 10/10/2006 | US7119165 Nogo receptor-mediated blockade of axonal growth |
| 10/10/2006 | US7119085 Inhibit amyloid protein deposits |
| 10/10/2006 | US7119080 Boronic ester and acid compounds, synthesis and uses |
| 10/10/2006 | US7119073 Peptides and their use as inhibitors of hepatitis C virus ns3 protease |
| 10/10/2006 | US7119072 Macrocyclic peptides active against the hepatitis C virus |
| 10/10/2006 | US7119071 Amino terminal substance P compositions and methods for using the same |
| 10/10/2006 | US7119063 Alzheimer's disease therapy; polypeptides |
| 10/10/2006 | US7118877 Identifying enzyme modulators for treating neurodegenerative, autoimmune and tumor diseases |
| 10/10/2006 | US7118872 Used in detection, isolation, and/or purification |
| 10/05/2006 | WO2006105386A1 Cdk2 inhibitors |
| 10/05/2006 | WO2006104190A1 Par-2 agonist |
| 10/05/2006 | WO2006104186A1 Dipeptide crystal and method for producing same |
| 10/05/2006 | WO2006103274A1 Age inhibitors |
| 10/05/2006 | WO2006103038A1 Substituted 1,2-ethylendiamines, medicaments comprising said compound; their use and their method of manufacture |
| 10/05/2006 | WO2006103015A1 Antibacterial amide-macrocycles v |
| 10/05/2006 | WO2006103009A1 Antibacterial amide macrocycles vi |
| 10/05/2006 | WO2004016736A3 Nucleic acids and corresponding proteins entitled 202p5a5 useful in treatment and detection of cancer |
| 10/05/2006 | US20060223984 Gamma-conopeptides |
| 10/05/2006 | US20060223761 Methods and compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
| 10/05/2006 | US20060223760 Compositions and methods for treatment of cancer |
| 10/05/2006 | US20060223759 Substituted 1,2-ethylenediamines, Methods for Preparing Them and Uses Thereof |
| 10/05/2006 | US20060223758 Treating treating angiogenic disease by administering therapeutically effective amount of compounds of the invention, for example, {(3R, 4S, 5S, 6R)-5-Methoxy-4-[(2R, 3R)-2-methyl-3-(3-methyl-but-2-enyl)-oxiranyl]-1-oxa-spiro[2.5]oct-6-yloxycarbonylamino}-3-methyl-butyric acid methyl ester; stability |
| 10/05/2006 | US20060223750 Agents and methods for enhancing photodynamic therapy |
| 10/05/2006 | US20060223745 Macrocyclic compounds having aspartic protease inhibiting activity and pharmaceutical uses thereof |
| 10/05/2006 | US20060222593 Peptide-chelate conjugates |
| 10/05/2006 | DE102005014247A1 Antibakterielle Amid-Makrozyklen VI Antibacterial amide macrocycles VI |
| 10/05/2006 | DE102005014245A1 Antibakterielle Amid-Makrozyklen V Antibacterial amide macrocycles V |
| 10/05/2006 | CA2603404A1 Substituted 1,2-ethylendiamines, medicaments comprising said compound; their use and their method of manufacture |
| 10/05/2006 | CA2603386A1 Age inhibitors |
| 10/05/2006 | CA2602755A1 Antibacterial amide-macrocycles v |
| 10/05/2006 | CA2602743A1 Antibacterial amide macrocycles vi |
| 10/04/2006 | EP1412328B1 Dolastatin 10 derivatives |
| 10/04/2006 | CN1842515A Cathepsin inhibitors |
| 10/03/2006 | US7115618 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication |
| 10/03/2006 | US7115607 Substituted piperazinyl amides and methods of use |
| 10/03/2006 | US7115573 Prodrug compounds with an isoleucine |
| 10/03/2006 | US7115566 For improved drug delivery |
| 10/03/2006 | US7115562 Peptides and their use to ameliorate cell death |
| 10/03/2006 | US7115389 Contacting L-alanine methyl ester as carboxy component and L-glutamine as amine component to an enzyme (E. coli JM 109) which catalyzes hydrolysis of amino acid ester to form a dipeptide; enzyme derived from a microorganism belonging to the genus Acetobacter |
| 10/03/2006 | US7115272 Polypeptide comprising the immunogenic portion of wilms' tumor suppressor gene(wt1); tumor-associated antigen for use in cancer immunotherapy |
| 10/03/2006 | US7115267 polypeptide comprising hemoglobin alpha chain wherein the C-terminal hydrophobic domain has been substituted or deleted; regulating stem cell cycle and accelerating the post-chemotherapy peripheral blood cell recovery; inhibitors and stimulators of stem cell proliferation. |
| 10/03/2006 | US7115266 Angiotensin peptide-carrier conjugates and uses thereof |
| 09/28/2006 | WO2006101858A1 Alpha-helix mimetics and methods relating to the treatment of fibrosis |
| 09/28/2006 | WO2006101422A1 Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof |
| 09/28/2006 | WO2006101187A1 Peptides that increase collagen or hyaluronic acid production |
| 09/28/2006 | WO2006085974A3 Amphiphilic dendritic dipeptides & their self-assembly into helical pores |
| 09/28/2006 | WO2006031330A3 METHOD OF REDUCING THE EFFECTS OF Aβ AND COMPOSITIONS THEREFORE |
| 09/28/2006 | WO2005072292A3 Methods for enhancing radiation therapy |
| 09/28/2006 | WO2004075830A3 Knockout identification of target-specific sites in peptides |
| 09/28/2006 | US20060217891 Method of designing physiologically active peptide and use thereof |
| 09/28/2006 | US20060217530 Active against C5a receptors on polymorphonuclear leukocytes and macrophages; peptidomimetics; for treatment of inflammation |
| 09/28/2006 | US20060217319 Method for modulating nod1 activity, use of a mtp related molecule for modulating nod1 activity, and therapeutic applications thereof |
| 09/28/2006 | US20060217318 Ace inhibitory peptides from plant materials |
| 09/28/2006 | US20060217295 Neuroprotective macrocyclic compounds and methods for their use |
| 09/28/2006 | US20060217294 Compounds binding to p-selectin |
| 09/28/2006 | US20060217292 Vitronectin receptor antagonist compounds and their use in the preparation of diopharmaceuticals |
| 09/28/2006 | CA2602545A1 Phenyl-n-acyl derivatives of amines and amino acids, a process for the preparation thereof, a pharmaceutical composition and the use thereof |
| 09/28/2006 | CA2601394A1 Immunogens for vaccines against antigenically variable pathogens and diseases |
| 09/27/2006 | EP1705255A2 Diagnostic method and kit for determining Kell blood group genotype |
| 09/27/2006 | EP1549334B1 Pharmaceutical composition comprising a retro-inverso isomer peptide |
| 09/27/2006 | EP0759786B1 Somatostatin binding peptide-metal chelate conjugates |
| 09/27/2006 | CN1839148A Cytotoxic depsipeptides |
| 09/27/2006 | CN1839147A Method for synthesis of perindopril and its pharmaceutically acceptable salts |
| 09/27/2006 | CN1837205A Process for the preparation of pyrazolopyridine tartrates |
| 09/26/2006 | USRE39308 3,5-dioxa-12-azawurtzitane compound and process of preparing same |
| 09/26/2006 | US7112654 Ligand for vascular endothelial growth factor receptor |
| 09/26/2006 | US7112590 Anticoagulant for mammals |
| 09/26/2006 | US7112570 Central nervous system disorders; brain disorders |
| 09/26/2006 | US7112562 Insulin conjugates and methods of use thereof |
| 09/21/2006 | WO2006099261A2 Potent and specific immunoproteasome inhibitors |
| 09/21/2006 | WO2006097774A1 Synthetic peptides containing unnatural adamantane-related amino acids for use as antitumour drugs |
| 09/21/2006 | WO2006097693A1 Convergent solid phase peptide synthesis by reaction of two fragments bound to solid support |
| 09/21/2006 | WO2002050303A3 Protein-protein interactions |
| 09/21/2006 | US20060211719 Heteroaryl aminoguanidine and alkoxyguanidines and their use as protease inhibitors |
| 09/21/2006 | US20060211659 Novel compounds of the N-acylamino amide family, compositions comprising them and uses thereof |
| 09/21/2006 | US20060211630 Novel synthetic compounds, processes of manufacture and uses in the treatment of integrin-mediated disorders |
| 09/21/2006 | US20060211629 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 09/21/2006 | US20060211078 Identifying enzyme modulators for treating neurodegenerative, autoimmune and tumor diseases |
| 09/21/2006 | US20060210972 Annotation of genome sequences |
| 09/20/2006 | EP1702985A2 Preferred segments of neural thread protein and methods of using the same |
| 09/20/2006 | EP1701974A2 Novel 2-hydroxytetrahydrofurane derivatives and use thereof as medicaments |
| 09/20/2006 | EP1701973A1 Glutathione derivatives and their uses for the treatment of viral diseases |
| 09/20/2006 | EP1276491B1 Tamandarin and didemnin analogs and methods of making and using them |
| 09/20/2006 | CN1835966A Novel method for the synthesis of perindopril and the pharmaceutically-acceptable salts thereof |
| 09/20/2006 | CN1835965A Novel method for the synthesis of perindopril and the pharmaceutically-acceptable salts thereof |
| 09/20/2006 | CN1835911A Novel method for synthesizing esters of N-[(S)-1-carboxybutyl]-(S)-alanine and use thereof for synthesizing perindopril |
| 09/20/2006 | CN1834088A Tetrapeptide derivative crystals |
| 09/20/2006 | CN1275979C Carboline carboxylic acid contaiing P6A associated sequence and synthesis and medical application thereof |
| 09/19/2006 | US7109323 lyophilization of an aqueous mixture comprising a boronic add compound and a compound having at least two hydroxyl groups produces a stable composition that readily releases the boronic acid compound upon dissolution in aqueous media |
| 09/19/2006 | US7109303 Modified cytokines for use in cancer therapy |
| 09/19/2006 | US7109165 Anticarcinogenic agent is conjugated with a nucleic acids, for cancer treatment; a kit for detection; chemical intermediates |
| 09/19/2006 | US7109160 Peptides containing the motif IGD and their use as cell migration modulators |
| 09/14/2006 | WO2006096652A2 Process for preparing macrocyclic compounds |
| 09/14/2006 | WO2006096213A1 Polyamine sensors and methods of using the same |
| 09/14/2006 | WO2004056849B1 Methanobactin: a copper binding compound having antibiotic and antioxidant activity isolated from methanotrophic bacteria |
| 09/14/2006 | WO2003089588A3 Novel molecules of the pyrin/nbs/lrr protein family and uses thereof |
| 09/14/2006 | US20060205923 For detecting the presence of FIV antibodies in a biological sample, bycontacting a biological sample from an animal with the FIV polypeptide |
| 09/14/2006 | US20060205673 2-Amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentanoic acid amide derivatives |
| 09/14/2006 | US20060205672 Novel peptides as NS3-serine protease inhibitors of hepatitis C virus |